Frederic Guerard
DirectorDr. Frederic Guerard, also known as Fred, Pharm. D., M.S., is President, CEO & Director at Qlaris Bio, Inc. since March 01, 2026. He was Chief Executive Officer of Opthea Limited from October 27, 2023 to September 1, 2025. He has been Independent Director at LENZ Therapeutics, Inc. since March 2024 and served on the LENZ OpCo board of directors from September 2021 through the closing of the Merger. He is a Director of CalciMedica, Inc. from March 2023. Dr. Guerard had been President and Chief Executive Officer at Graybug Vision, Inc since February 2019 and served as its Secretary. From 1999 to February 2019, he serves as Director of Spiral Therapeutics, Inc. since March 29, 2023. He serves as a non-executive director on the boards of Lenz Therapeutics, CalciMedica, Spiral Therapeutics and Unither Pharmaceuticals. Dr. Guerard served as the President and Chief Executive Officer of Graybug Vision, Inc. from February 2019 until March 2023. Dr. Guerard held key leadership roles at Novartis AG, a multinational pharmaceutical company, including Worldwide Business Franchise Head of Ophthalmology from April 2016 to February 2019, Global Franchise Head of Pharmaceuticals at Alcon Vision LLC, a Novartis company, from May 2015 to April 2016, Managing Director of the United Kingdom and Ireland from July 2012 to April 2015 and Country President and Managing Director of Australia and New Zealand from April 2009 to July 2012. Dr. Guerard joined Alcon in April 2015 from Novartis Pharma, where most recently he served as CPO Head for the United Kingdom & Ireland. Dr. Guerard joined Novartis in 1997 as a Project Manager. Dr. Guerard has played a key role in growing and developing mature and emerging markets, leading his teams with integrity to achieve breakthrough results. Prior to joining Novartis, Dr. Guerard held regional and international product management positions with Servier Laboratories. Prior to this role, he served as Global Franchise Head of Pharmaceuticals at Alcon. He has also held multiple leadership positions at Novartis, including Head of United Kingdom and Ireland, Head and Country President of Australia and New Zealand, Head of Marketing and Sales for Emerging Growth Markets Region, Head and Country President Egypt and Cluster Head North and West Africa. He has served on the Board of the Association of the British Pharmaceutical Industry (ABPI) and on the Board of Medicines Australia. Dr. Guerard holds Pharm. D. and a Master of Biological and Medical Sciences from the University of Rouen, France and a Master of Marketing Degree from HEC Paris School of Management.
公司職務
- 公司名稱CalciMedica, Inc.股票代碼CALC職務Director共事同僚
- ARA. Rachel LehenyCEO & Director
- RNRobert N. WilsonIndependent Chairman of the Board
- EWEric W. RobertsChief Business Officer & Vice Chairman of the Board
- SHSudarshan HebbarChief Medical Officer
- MJMichael J. DunnPresident & COO
- ARAnjana RaoCo-Founder and Scientific Advisor
- AJAllan J. Lee ShawIndependent Director
- 公司名稱LENZ Therapeutics, Inc.股票代碼LENZ職務Independent Director共事同僚
- EBEvert B. SchimmelpenninkPresident, CEO, Secretary & Director
- JPJeffrey P. GeorgeIndependent Chairman
- JWJames W. McCollumCo-Founder & Director
- SOShawn OlssonChief Commercial Officer
- MGMarc G. OdrichChief Medical Officer
- DRDaniel R. ChevallardCFO, Principal Financial & Accounting Officer
- FGFrederic GuerardIndependent Director
- SBShelley B. ThunenIndependent Director
